| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |